Literature DB >> 8175848

Early migration and late aseptic failure of proximal femoral prostheses.

M A Freeman1, P Plante-Bordeneuve.   

Abstract

The vertical migration of four configurations of a proximal femoral prosthesis, followed for up to nine years, was measured on standard radiographs. The same implant was used without cement (group 1) and with cement (group 2). The migration of both groups was linear from six months onwards. The mean migration rate and the incidence of late aseptic loosening were both greater in group 1. Survival analysis of the two groups, however, showed no statistically significant difference. In both groups, hips later destined for revision migrated more rapidly from the initial postoperative period onwards, than did the remainder. A threshold migration of 1.2 mm/year during the first two years after implantation detected hips likely to fail with a specificity of 86% and a sensitivity of 78%. This 'migration test' was applied to the results in two further groups of patients in which a modified femoral prosthesis had been implanted without hydroxyapatite coating (group 3) and with hydroxyapatite coating (group 4). The test distinguished between the four groups and suggested that at least two fixation procedures should be abandoned. We conclude that vertical migration measured on standard radiographs in the first two years after implantation can be used to predict late aseptic loosening. New prosthetic configurations should be evaluated by migration measurements before their general release. Our observations support the view that one cause of late aseptic loosening is imperfect initial fixation.

Entities:  

Mesh:

Year:  1994        PMID: 8175848

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  41 in total

1.  How long should patients be followed-up after total hip replacement? Current practice in the UK.

Authors:  M J Bankes; R Coull; B D Ferris
Journal:  Ann R Coll Surg Engl       Date:  1999-09       Impact factor: 1.891

2.  [The cemented MS-30 stem. A multi-surgeon series of 333 consecutive cases].

Authors:  M Clauss; T Reitzel; M Pritsch; U J Schlegel; R G Bitsch; V Ewerbeck; H Mau; S J Breusch
Journal:  Orthopade       Date:  2006-07       Impact factor: 1.087

3.  Stem-cement porosity may explain early loosening of cemented femoral hip components: experimental-computational in vitro study.

Authors:  Kenneth A Mann; Leatha A Damron; Mark A Miller; Amos Race; Michael T Clarke; Richard J Cleary
Journal:  J Orthop Res       Date:  2007-03       Impact factor: 3.494

4.  Aseptic stem loosening in primary THA: migration analysis of cemented and cementless fixation.

Authors:  Artur Kroell; Paul Beaulé; Martin Krismer; Hannes Behensky; Bernd Stoeckl; Rainer Biedermann
Journal:  Int Orthop       Date:  2008-12-06       Impact factor: 3.075

5.  Neck-preserving femoral stems.

Authors:  Karthig Rajakulendran; Richard E Field
Journal:  HSS J       Date:  2012-09-07

6.  Accuracy of model-based RSA contour reduction in a typical clinical application.

Authors:  Christof Hurschler; Frank Seehaus; Judith Emmerich; Bart L Kaptein; Henning Windhagen
Journal:  Clin Orthop Relat Res       Date:  2008-05-29       Impact factor: 4.176

Review 7.  Total hip replacement: the way forward.

Authors:  C Bulstrode
Journal:  Ann R Coll Surg Engl       Date:  1996-03       Impact factor: 1.891

8.  Progressive femoral cortical and cancellous bone density loss after uncemented tapered-design stem fixation.

Authors:  Lutz A Mueller; Tobias E Nowak; Lothar Haeberle; Lars P Mueller; Alexander Kress; Michael Voelk; David Pfander; Raimund Forst; Rainer Schmidt
Journal:  Acta Orthop       Date:  2010-04       Impact factor: 3.717

9.  Notes on the use and interpretation of radiostereometric analysis.

Authors:  Brian Derbyshire; Robin J Prescott; Martyn L Porter
Journal:  Acta Orthop       Date:  2009-02       Impact factor: 3.717

10.  Once-weekly oral medication with alendronate does not prevent migration of knee prostheses: A double-blind randomized RSA study.

Authors:  Ulrik Hansson; Sören Toksvig-Larsen; Leif Ryd; Per Aspenberg
Journal:  Acta Orthop       Date:  2009-02       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.